Evidence map›Paper›PMID 39415207›Full record

ReviewGlobalization and health2024

AMR and Sustainable Development Goals: at a crossroads.

Bilal Aslam, Rubab Asghar, Saima Muzammil, Muhammad Shafique, Abu Baker Siddique, Mohsin Khurshid, Muhammad Ijaz, Muhammad Hidayat Rasool, Tamoor Hamid Chaudhry, Afreenish Aamir and 1 more

Abstract readReview
In one paragraph

Review in Globalization and health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Antimicrobial resistantOne health (Amsterdam, Netherlands) · 2026
    Review
  14. Discovery of new bioactive secondary metabolites from the stem bark of oroxylum indicum: isolation, structural identification, antimicrobial and cytotoxicity assessment.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. In Silico Druggability Assessment ofAntibiotics (Basel, Switzerland) · 2026
    Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bilal Aslam *Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan. drbilalaslam@gcuf.edu.pk.
Rubab Asghar *Institute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Saima MuzammilInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad ShafiqueInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Abu Baker SiddiqueInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Mohsin KhurshidInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad IjazInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad Hidayat RasoolInstitute of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Tamoor Hamid ChaudhryNational Institute of Health, Islamabad, Pakistan.
Afreenish AamirNational Institute of Health, Islamabad, Pakistan.
Zulqarnain Baloch *Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, People's Republic of China. znbaloch@yahoo.com.ORCID 0000-0002-7873-1343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a significant global health threat, primarily stemming from its misuse and overuse in both veterinary and public healthcare systems. The consequences of AMR are severe, leading to more severe infections, increased health protection costs, prolonged hospital stays, unresponsive treatments, and elevated fatality rates. The impact of AMR is direct and far-reaching, particularly affecting the Sustainable Development Goals (SDGs), underscoring the urgency for concerted global actions to achieve these objectives. Disproportionately affecting underprivileged populations, AMR compounds their vulnerabilities, pushing them further into poverty. Moreover, AMR has ramifications for food production, jeopardizing sustainable agriculture and diminishing the livelihoods of farmers. The emergence of antibiotic-resistant bacteria in underprivileged areas heightens the risk of complications and mortality. Climate change further contributes to AMR, as evidenced by increased instances of foodborne salmonellosis and the development of antibiotic resistance, resulting in substantial healthcare costs. Effectively addressing AMR demands collaboration among governments, entrepreneurs, and the public sector to establish institutions and policies across all regulatory levels. Expanding SDG 17, which focuses on partnerships for sustainable development, would facilitate global antimicrobial stewardship initiatives, technology transfer, surveillance systems, and investment in vaccine and drug research. The World Bank's SDG database, tracking progress towards sustainable development, reveals a concerning picture with only a 15% success rate till 2023 and 48% showing deviation, underscoring a global gap exacerbated by the COVID-19 pandemic. Tackling AMR's global impact necessitates international cooperation, robust monitoring, and evaluation methods. The five priorities outlined guide SDG implementation, while impoverished countries must address specific challenges in their implementation efforts. Addressing AMR and its impact on the SDGs is a multifaceted challenge that demands comprehensive and collaborative solutions on a global scale.

Indexed as

Global HealthSustainable DevelopmentAntimicrobial StewardshipDrug Resistance, MicrobialGoalsHumansAlternatives to AntibioticsAntimicrobial Resistance (AMR)Antimicrobial StewardshipOne HealthSocio-Economic ImpactsSustainable Development Goals (SDGs)

Identifiers

PMID39415207
PMCPMC11484313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.